Manufacturing problems that delay a drug launch can cost a company tens of millions of dollars in revenues. A warning letter for a plant might result in hundreds of millions in investments. But what ...

ETEnergyworld.com brings latest dilip shanghvi news, views and updates from all top sources for the Indian Energy industry.

How Dilip Shanghvi turned a Rs 10,000 loan into a $45 billion pharma giant, building Sun Pharma through calculated bets, global acquisitions, and a strategic pivot to specialty drugs.

In 1983, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) to manufacture psychiatric drugs. Shanghvi grew Sun Pharmaceutical Industries ...

New Delhi: Sun Pharmaceuticals is one of India's as well as the world's leading drug manufacturing companies and has made a name for itself in the pharmaceutical industry. It was found by Dilip ...

Who are the world's richest billionaires? According to Forbes' latest list, 22 people with pharma interests made the top 500, and Asian drug magnates are among them: four from India and one from China ...

MUMBAI – India's Sun Pharmaceutical Industries Ltd Managing Director Dilip Shanghvi said he expects Ranbaxy Laboratories Ltd to become profitable in the short term. Sun said it will buy Ranbaxy in a ...

Ladies and gentlemen, good day, and welcome to the Q4 FY '23 Earnings Conference Call of Sun Pharmaceuticals Industries Limited. As a reminder, all participants lines will be in the listen-only mode, ...

Sun Pharma's growth in the last five years cannot be ignored. And neither can its founder-leader Dilip Shanghvi who has become the stuff of legends as he continues to grow and consolidate his Rs ...

Just when pharma tycoon Dilip Shanghvi must have been thinking his troubles at Sun Pharmaceutical Industries were behind him, they've come back. Shanghvi's latest headache stems from a report by ...